-
1
Bayesian methods in health economics
Published 2009Table of Contents: “…Contents: The primary way to account for uncertainty in health economic evaluation is probabilistic sensitivity analysis (PSA) -- PSA is increasingly demanded as a part of economic evaluation to justify a claim of cost-effectiveness for new drugs and procedures -- Economic modeling and uncertainty in economic models -- Three steps for PSA: formulating uncertainty on model inputs, computing the implied uncertainty regarding model outputs, and expressing that uncertainty in ways that are useful to decision makers -- Case study: economic model to assess cost-effectiveness of a new vaccine.…”
Get full text
Series
Electronic Video -
2
Probabilistic sensitivity analysis
Published 2009Table of Contents: “…Contents: The primary way to account for uncertainty in health economic evaluation is probabilistic sensitivity analysis (PSA) -- PSA is increasingly demanded as a part of economic evaluation to justify a claim of cost-effectiveness for new drugs and procedures -- Economic modeling and uncertainty in economic models -- Three steps for PSA: formulating uncertainty on model inputs, computing the implied uncertainty regarding model outputs, and expressing that uncertainty in ways that are useful to decision makers -- Case study: economic model to assess cost-effectiveness of a new vaccine.…”
Get full text
Series
Electronic Video -
3
Probabilistic sensitivity analysis
Published 2009Table of Contents: “…Contents: The primary way to account for uncertainty in health economic evaluation is probabilistic sensitivity analysis (PSA) -- PSA is increasingly demanded as a part of economic evaluation to justify a claim of cost-effectiveness for new drugs and procedures -- Economic modeling and uncertainty in economic models -- Three steps for PSA: formulating uncertainty on model inputs, computing the implied uncertainty regarding model outputs, and expressing that uncertainty in ways that are useful to decision makers -- Case study: economic model to assess cost-effectiveness of a new vaccine.…”
Get full text
Series
Electronic Video